Fengyuan Pharmaceutical revenues in 2008 net profit 870 million to double - Fengyuan Pharmaceutical - pharmaceutical industries

In 2008, snow, earthquakes natural disasters and affect the global financial crisis, China's economy had a greater impact. National health system reform policies have been put forward market pharmaceutical production business has and will continue to undergo major changes. The face of complex and volatile external environment, the company through overcoming raw materials and energy prices, many Chinese industrial policy adjustment difficulties, unity of thinking, closely around the beginning of the established objectives and development strategy, adhere to the profit center to strengthen the marketing, attention to basic management, and actively respond to market changes, exceeded the goals set at beginning of the year. 2008 companies were realized main business income of 873,807,900 yuan, up 24.16 percent over last year; to achieve operating profit 19,855,500 yuan, up 32.07 percent over last year; a net profit of 15.1975 million yuan , increase of 158.05 percent over the same period last year.

1. Strategic Planning The reporting period, the company through the team approach to learning and full participation by the discussions on the benchmark companies, competitors and business carry out a comprehensive analysis of internal and external environment, the establishment of the company's overall development strategy and planning, specifically the company's development Vision, Mission and the "Three Represents" from "four serious," "five to" the core management philosophy, actively implement the strategic measures and the protection of the annual plan.

2. Pharmaceutical Affairs and Technology Innovation 2008, the Company has received two varieties specifications infusion 9 Generic Production approval document, 3 Traditional Chinese medicine Product production licenses and injection of pantoprazole &? Write? Fly ?????? than the norm? Towering? Oh Qiong Wan gluttonous school scores grazing ? threat bran snapped Xuehuang Ken bud? International stool? T Xu International Festival onion Road Jiao Gui? ü? the transformation of brain Secular? Rong?? broom? White bream Island oysters are what Hong die?> ignorant of the Si-managing the edge of wood? squint box?

3. Quality management: strict implementation of national drug manufacturing practices (GMP), to enhance the quality of full awareness and production skills training, efforts to improve product quality. Complete the second phase of production areas, Su Ping Guzhen infusion line state "GMP" certified commissioning work; the completion of reconstruction projects fructose raw materials all the preparations before certification; to complete the company more business units "GSP" re-certification.

4. Marketing Management

Strengthen the development of marketing strategy, combined with the implementation of intensive regional orientation, respectively, to enhance the expansion of sales network integration and other policies; established drugs Tender The Committee on the bidding process for the whole monitoring; price committee set up to formulate a reasonable price strategy; perfect sales system, with the focus of the aging management of trade receivables; enhance customer management, build customer profiles, e-forms; optimize existing sales force integration, improve the overall quality of the company's sales force and operational capacity; investment in the establishment of "Chinese Import and Export Co., Ltd. Anhui BBCA" in order to speed up the pace of our products into international markets.

I am an expert from repairtestequipments.com, while we provides the quality product, such as XDECTM ECU Manufacturer , 12PSB Test Bench Manufacturer, repair test equipment suppliers,and more.